missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human DOK1 Synthetic Peptide

Product Code. 15206479
Change view
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Product Code. Quantity unitSize
15206479 50 μg 50µg
1 options
This item is not returnable. View return policy

Product Code. 15206479

Brand: Invitrogen™ PEP0257

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Synthetic Peptide

DOK1 Synthetic Peptide, PEP-0257, from Invitrogen.

DOK1 (P62dok, Docking protein 1) is believed to be a mainly cytoplasmic adaptor protein which down-regulates mitogen-activated protein kinase activation, inhibits cell proliferation and transformation, and promotes cell spreading and cell migration. DOK1 is a major substrate for many tyrosine kinases including c-kit, v-abl, vFPS, EGF, and PDGF. Upon phosphorylation by kinases, DOK1 forms a complex with ras GTPase-activating protein. Phosphorylation on tyrosine residues by the insulin receptor kinase results in the negative regulation of the insulin signaling pathway. DOK1 contains a putative pleckstrin homology domain at the amino terminus and ten PXXP SH3 recognition motifs.
TRUSTED_SUSTAINABILITY

Specifications

Gene ID (Entrez) 1796
Species Human
Purification Method purified
Accession Number Q99704
Common Name Human DOK1
Concentration 200 μg/mL
Content And Storage -20°C
Description Synthetic Peptide
Format Liquid
Formulation PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For Use With (Application) Blocking Assay, Control
Gene Symbol DOK1
Lyophilized No
Preservative 0.02% sodium azide
Product Type Peptide
Quantity 50 μg
Regulatory Status RUO - research use only
Storage Buffer PBS
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.